SEC Form 4 · accession 0001230724-26-000016
Vaxcyte, Inc. · PCVX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew Guggenhime
Officer — PRESIDENT AND CFO
Period of report
Aug 31, 2026
Accepted (ET)
Sep 2, 2026 · 7:56 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001649094
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 31, 2026 | F | 1,273 | $60.74 | D | 103,903 | D | |
| Common StockF1 | Sep 2, 2026 | F | 1,432 | $61.58 | D | 102,471 | D | |
| Common StockF2 | holding | — | — | — | 61,850 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs.
- F2Shares are held by ALG 2025 GRAT HOLDINGS LLC, of which 100% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person is the annuitant and the trustee.